Literature DB >> 3783345

Studies on anthelmintic effects of flubendazole and mebendazole on the rat lungworm Angiostrongylus cantonensis in mice and rats.

J Maki, T Yanagisawa.   

Abstract

Flubendazole and mebendazole given orally at 10 mg/kg/day 5-7 days post-infection (total 30 mg/kg) were found to eliminate 93-100% of Angiostrongylus cantonensis larvae in mice and rats. No significant difference was observed between the effects of the 2 drugs. The effectiveness of the drugs decreased with the increase in days post-infection on which medication was administered. It was found possible to treat A. cantonensis adults in rats by administering flubendazole or mebendazole at 10 mg/kg/day for 10 consecutive days. The drugs exhibited better anthelmintic efficacy in a divided dosing regimen than in a single dosing regimen.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3783345

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  6 in total

Review 1.  Clinical aspects of eosinophilic meningitis and meningoencephalitis caused by Angiostrongylus cantonensis, the rat lungworm.

Authors:  Gerald S Murphy; Stuart Johnson
Journal:  Hawaii J Med Public Health       Date:  2013-06

2.  Animal model of human disease with optic neuritis: neuropapillitis in a rat model infected with Angiostrongylus cantonensis.

Authors:  Ying Feng; Xin Zeng; Wei-hua Li; Wen-cong Wang; Li-si Ou-Yang; Xi Sun; Zhiyue Lv; Zhong-Dao Wu
Journal:  Parasitol Res       Date:  2014-08-31       Impact factor: 2.289

3.  The efficacy of therapy with albendazole in mice with parasitic meningitis caused by Angiostrongylus cantonensis.

Authors:  K P Lan; C J Wang; S C Lai; K M Chen; S S Lee; J D Hsu; H H Lee
Journal:  Parasitol Res       Date:  2004-06-04       Impact factor: 2.289

4.  Combined treatment with interleukin-12 and mebendazole lessens the severity of experimental eosinophilic meningitis caused by Angiostrongylus cantonensis in ICR mice.

Authors:  Wen-Yuan Du; Jiunn-Wang Liao; Chia-Kwung Fan; Kua-Eyre Su
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

5.  Co-Therapy of Albendazole and Dexamethasone Reduces Pathological Changes in the Cerebral Parenchyma of Th-1 and Th-2 Dominant Mice Heavily Infected with Angiostrongylus cantonensis: Histopathological and RNA-seq Analyses.

Authors:  Kai-Yuan Jhan; Chien-Ju Cheng; Shih-Ming Jung; Yi-Jen Lai; Kuang-Yao Chen; Lian-Chen Wang
Journal:  Biomolecules       Date:  2021-04-06

Review 6.  Clinical Efficacy and Safety of Albendazole and Other Benzimidazole Anthelmintics for Rat Lungworm Disease (Neuroangiostrongyliasis): A Systematic Analysis of Clinical Reports and Animal Studies.

Authors:  John Jacob; Argon Steel; Zhain Lin; Fiona Berger; Katrin Zöeller; Susan Jarvi
Journal:  Clin Infect Dis       Date:  2022-04-09       Impact factor: 9.079

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.